1981
DOI: 10.1111/j.1600-0447.1981.tb00679.x
|View full text |Cite
|
Sign up to set email alerts
|

Functional and structural rat kidney changes caused by peroral or parenteral lithium treatment

Abstract: Renal functional and structural changes were studied in rats treated with lithium for 5 months. The lithium was administered in two different ways: in the food or as a daily intrapentoned injection. In the perorally treated rats serum lithium was relatively constant during the day. In the injected rats serum lithium reached a high peak value just after the injection followed by a decrease to very low values. In all rats an increased water consumption and a reduced renal concentratia ability were seen during li… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
16
0

Year Published

1984
1984
2015
2015

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 65 publications
(20 citation statements)
references
References 12 publications
4
16
0
Order By: Relevance
“…19 Serum lithium levels were not determined, but the mice were injected daily with 4 mg lithium chloride (approximately 120 mg/kg body wt), which likely resulted in lithium levels within the therapeutic range (0.6-1.0 mM). 86 It remains to be determined why this dose improved the kidney function of lupus mice, whereas it causes renal disease in other animals and humans. 86 Finally, rats that were injected 30 minutes before ischemia-reperfusion with lithium displayed reduced levels of renal oxidative stress, because they exhibited a diminished mitochondrial membrane depolarization and reactive oxygen species (ROS) production.…”
Section: Lithium Reduces Kidney Damage In Various Nephropathy Modelsmentioning
confidence: 99%
See 1 more Smart Citation
“…19 Serum lithium levels were not determined, but the mice were injected daily with 4 mg lithium chloride (approximately 120 mg/kg body wt), which likely resulted in lithium levels within the therapeutic range (0.6-1.0 mM). 86 It remains to be determined why this dose improved the kidney function of lupus mice, whereas it causes renal disease in other animals and humans. 86 Finally, rats that were injected 30 minutes before ischemia-reperfusion with lithium displayed reduced levels of renal oxidative stress, because they exhibited a diminished mitochondrial membrane depolarization and reactive oxygen species (ROS) production.…”
Section: Lithium Reduces Kidney Damage In Various Nephropathy Modelsmentioning
confidence: 99%
“…86 It remains to be determined why this dose improved the kidney function of lupus mice, whereas it causes renal disease in other animals and humans. 86 Finally, rats that were injected 30 minutes before ischemia-reperfusion with lithium displayed reduced levels of renal oxidative stress, because they exhibited a diminished mitochondrial membrane depolarization and reactive oxygen species (ROS) production. 13 In addition, a 30-day pretreatment of rats with lithium reduced renal damage induced by ischemia-reperfusion, which was shown by the reduction in BUN and serum creatinine and the improved preservation of the tubular structure.…”
Section: Lithium Reduces Kidney Damage In Various Nephropathy Modelsmentioning
confidence: 99%
“…intake of 0.9% NaCl (18)(19)(20). This regimen prevents intermittent sharp increases in plasma Li above the therapeutic range (17,22) and prevents sodium depletion that leads to acute Li nephrotoxicity (19,20,22).…”
Section: Introductionmentioning
confidence: 99%
“…In view of these considerations, we analyzed the animal model of Li-induced polyuria, which closely duplicates renal effects of chronic Li administration encountered in humans (17)(18)(19)(20)(21). In this model, the Li is administered to rats orally for at least several weeks in solid food, simultaneously with ad lib.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation